Last updated on 6th March 2011
This is a very brief blog entry to signpost a couple of recent National Institute for Health and Clinical Excellence (NICE) guidelines on the management of bed-wetting in children & young people (up to age 19), and on the prevention of osteoporosis in adults. These are both subjects that I'm sometimes asked about, and high quality, up-to-date, evidence-based advice is well worthwhile.
If you're really interested in bed-wetting, you can read or download the full 473 page "Nocturnal enuresis: The management of bedwetting in children and young people" guideline. Happily there is also a 20 page "Quick reference guide" written for health professionals, and also another 20 page booklet "Bedwetting in children and young people" written for parents, carers & young people themselves.
Osteoporosis prevention is covered in two guidelines - the 94 page amended "Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women" with a 4 page, health professional "Quick reference guide" and a 6 page "Patient/general public guide". There's also a 99 page "Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended)" with a 4 page professional "Quick reference guide" and a 6 page "Patient/general public guide" for postmenopausal women who have already suffered an osteoporotic fracture.